wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38032311-011D565A-F0E2-468E-B515-52ED46350CBB
Q38032311-011D565A-F0E2-468E-B515-52ED46350CBB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38032311-011D565A-F0E2-468E-B515-52ED46350CBB
Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration.
P2860
Q38032311-011D565A-F0E2-468E-B515-52ED46350CBB
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38032311-011D565A-F0E2-468E-B515-52ED46350CBB
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c028e7df081d9c325280816eb25962226a5d6464
P2860
Ranibizumab (Lucentis) in neovascular age-related macular degeneration: evidence from clinical trials.